+1,046.2%
MPWR vs MRNA
+794.5%
+251.7%
-51.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -4.8% | +4.4% | -0.1% |
| 7D | -11.3% | -20.9% | +9.5% | -9.5% |
| 30D | +4.6% | -13.3% | +17.8% | +5.9% |
| 3M | -1.5% | +212.6% | -214.1% | -18.3% |
| 6M | -11.5% | +309.0% | -320.6% | -30.7% |
| YTD | +45.4% | +567.3% | -522.0% | +3.7% |
| 1Y | +54.0% | +689.7% | -635.7% | +6.4% |
| 3Y | +148.1% | +157.4% | -9.4% | +95.2% |
| 5Y | +142.4% | -21.7% | +164.1% | +110.7% |
| All | +1,046.2% | +794.5% | +251.7% | +779.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling